BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 26048404)

  • 1. Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study.
    Tan WC; Sin DD; Bourbeau J; Hernandez P; Chapman KR; Cowie R; FitzGerald JM; Marciniuk DD; Maltais F; Buist AS; Road J; Hogg JC; Kirby M; Coxson H; Hague C; Leipsic J; O'Donnell DE; Aaron SD;
    Thorax; 2015 Sep; 70(9):822-9. PubMed ID: 26048404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: first report by the WHO-GARD survey group.
    Mohammad Y; Shaaban R; Al-Zahab BA; Khaltaev N; Bousquet J; Dubaybo B
    Int J Chron Obstruct Pulmon Dis; 2013; 8():473-82. PubMed ID: 24124359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study.
    Thomsen M; Nordestgaard BG; Vestbo J; Lange P
    Lancet Respir Med; 2013 Sep; 1(7):543-50. PubMed ID: 24461615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
    Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
    Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Airflow obstruction in never smokers in five Latin American cities: the PLATINO study.
    Perez-Padilla R; Fernandez R; Lopez Varela MV; Montes de Oca M; Muiño A; Tálamo C; Brito Jardim JR; Valdivia G; Baptista Menezes AM
    Arch Med Res; 2012 Feb; 43(2):159-65. PubMed ID: 22475778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive smoking exposure is associated with increased risk of COPD in never smokers.
    Hagstad S; Bjerg A; Ekerljung L; Backman H; Lindberg A; Rönmark E; Lundbäck B
    Chest; 2014 Jun; 145(6):1298-1304. PubMed ID: 24356778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.
    Kirby M; Tanabe N; Tan WC; Zhou G; Obeidat M; Hague CJ; Leipsic J; Bourbeau J; Sin DD; Hogg JC; Coxson HO; ; ;
    Am J Respir Crit Care Med; 2018 Jan; 197(1):56-65. PubMed ID: 28886252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Radicioni G; Ceppe A; Ford AA; Alexis NE; Barr RG; Bleecker ER; Christenson SA; Cooper CB; Han MK; Hansel NN; Hastie AT; Hoffman EA; Kanner RE; Martinez FJ; Ozkan E; Paine R; Woodruff PG; O'Neal WK; Boucher RC; Kesimer M
    Lancet Respir Med; 2021 Nov; 9(11):1241-1254. PubMed ID: 34058148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study.
    van Gemert F; Kirenga B; Chavannes N; Kamya M; Luzige S; Musinguzi P; Turyagaruka J; Jones R; Tsiligianni I; Williams S; de Jong C; van der Molen T
    Lancet Glob Health; 2015 Jan; 3(1):e44-51. PubMed ID: 25539969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
    Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
    Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender and chronic obstructive pulmonary disease in high-risk smokers.
    de Torres JP; Campo A; Casanova C; Aguirre-Jaime A; Zulueta J
    Respiration; 2006; 73(3):306-10. PubMed ID: 16330871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-reversible airway obstruction in never smokers: results from the Austrian BOLD study.
    Lamprecht B; Schirnhofer L; Kaiser B; Buist S; Studnicka M
    Respir Med; 2008 Dec; 102(12):1833-8. PubMed ID: 18722100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study.
    Tan WC; Bourbeau J; Hernandez P; Chapman KR; Cowie R; FitzGerald JM; Marciniuk DD; Maltais F; Buist AS; O'Donnell DE; Sin DD; Aaron SD;
    Thorax; 2014 Aug; 69(8):709-17. PubMed ID: 24706040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COPD among non-smokers - report from the obstructive lung disease in Northern Sweden (OLIN) studies.
    Hagstad S; Ekerljung L; Lindberg A; Backman H; Rönmark E; Lundbäck B
    Respir Med; 2012 Jul; 106(7):980-8. PubMed ID: 22498109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey.
    Celli BR; Halbert RJ; Nordyke RJ; Schau B
    Am J Med; 2005 Dec; 118(12):1364-72. PubMed ID: 16378780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare disease.
    O'Brien ME; Pennycooke K; Carroll TP; Shum J; Fee LT; O'Connor C; Logan PM; Reeves EP; McElvaney NG
    COPD; 2015 May; 12 Suppl 1():2-9. PubMed ID: 25938284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Findings on Thoracic Computed Tomography Scans and Respiratory Outcomes in Persons with and without Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.
    Tan WC; Hague CJ; Leipsic J; Bourbeau J; Zheng L; Li PZ; Sin DD; Coxson HO; Kirby M; Hogg JC; Raju R; Road J; O'Donnell DE; Maltais F; Hernandez P; Cowie R; Chapman KR; Marciniuk DD; FitzGerald JM; Aaron SD;
    PLoS One; 2016; 11(11):e0166745. PubMed ID: 27861566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic airflow limitation and its relation to respiratory symptoms among ever-smokers and never-smokers: a cross-sectional study.
    Toren K; Schiöler L; Lindberg A; Andersson A; Behndig AF; Bergström G; Blomberg A; Caidahl K; Engvall J; Eriksson M; Hamrefors V; Janson C; Kylhammar D; Lindberg E; Lindén A; Malinovschi A; Persson HL; Sandelin M; Eriksson Ström J; Tanash HA; Vikgren J; Östgren CJ; Wollmer P; Sköld CM
    BMJ Open Respir Res; 2020 Aug; 7(1):. PubMed ID: 32759170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history.
    Liu Y; Pleasants RA; Croft JB; Wheaton AG; Heidari K; Malarcher AM; Ohar JA; Kraft M; Mannino DM; Strange C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1409-16. PubMed ID: 26229460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD.
    Bourbeau J; Tan WC; Benedetti A; Aaron SD; Chapman KR; Coxson HO; Cowie R; Fitzgerald M; Goldstein R; Hernandez P; Leipsic J; Maltais F; Marciniuk D; O'Donnell D; Sin DD; Cancold Study Group
    COPD; 2014 Apr; 11(2):125-32. PubMed ID: 22433011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.